Shots:James gave an overview of the timeline of Recce Pharmaceuticals' clinical programs with several significant data read-outs in 2022 and 2023He emphasized the study design and results from the different infectious disease clinical and preclinical programs in its product portfolioThe interview highlights how the development and commercialization of New Classes of Synthetic Anti-Infectives…